Item-three - OmicsDI

Show results for

Unknown (4152)
Transcriptomics (39)
Proteomics (16)
Genomics (9)
Metabolomics (7)
Clinical (4)
Genomic (1)

Organisms

Chlamydomonas reinhardtii (16)
Pseudomonas canadensis (16)
Marchantia polymorpha subsp. ruderalis (16)
Methylocystis sp. (16)
Porites pukoensis (16)
Bothrops insularis (16)
Bothrops jararaca (16)
Bothrops jararacussu (16)
Bothrops cotiara (16)
Streptomyces coelicolor (16)
Pseudomonas taiwanensis (16)
Burkholderia ubonensis MSMB22 (16)
Pseudomonas aeruginosa PA103 (16)
Artibeus jamaicensis (16)
Mus musculus (11)
Homo sapiens (8)
Rattus norvegicus (5)
Pimephales promelas (2)
Danio rerio (2)
Arabidopsis thaliana (2)
Salmo trutta (1)
Crassostrea virginica (1)
Culex quinquefasciatus (1)
Citrus reticulata (1)
Gasterosteus aculeatus (1)
Porphyromonas gingivalis (1)
Oryza sativa (1)
Oncorhynchus mykiss (1)
Bos taurus (1)
Drosophila melanogaster (1)

Organisms

Streptomyces fuscus (1)
Rattus norvegicus (1)
Mus musculus (1)

Repository

biostudies-arrayexpress (39)
pride (16)
MetaboLights (7)
ENA (7)
EGA (2)
dbGaP (1)

Tissue

Cell culture (4)
Lung (2)
Nephrocyte (1)
Nasal mucosa (1)
Seed (1)
Urine (1)
Macrophage (1)
Brain (1)
Liver (1)
Blood (1)

Disease

Non diseased (1)
TAC operated 5 hours after surgery (1)
Breast cancer (1)
Malignant neoplasm of oesophagus (1)
Cancer (1)
Colonic Neoplasms (1)
Diarrhea (1)
Cutaneous malignant melanoma 1 (1)
Non-small cell lung carcinoma (1)

Technology Type

Mass Spectrometry (16)
Bottom-up proteomics (6)
Mass spectrometry (5)
Shotgun proteomics (5)
Data-dependent acquisition (4)
Mass spectrometry assay (2)
ABI_SOLID, Illumina HiSeq 2000, Illumina 450K, AB 5500xl Genetic Analyzer, AB 5500 Genetic Analyzer, ILLUMINA (1)
MSE (1)
All-ion fragmentation (1)
SWATH MS (1)
Data-independent acquisition (1)
Gel-based experiment (1)
Affinity purification coupled with mass spectrometry proteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (4)
Liquid Chromatography MS - negative - reverse phase (3)
Illumina NovaSeq X (2)
Illumina NovaSeq 6000 (2)
Autoflex speed smartbeam (1)
6490 Triple Quadrupole LC/MS (Agilent) (1)
Gas Chromatography MS - positive (1)
6540 Q-TOF LC/MS (Agilent) (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2026 (8)
2025 (7)
2008 (6)
2017 (5)
2014 (4)
2009 (4)
2015 (3)
2013 (3)
2010 (3)
2024 (2)
2018 (2)
2012 (2)
2011 (2)
2007 (2)
2023 (2)
2020 (2)
2006 (1)
2004 (1)
2022 (1)
2016 (1)
2019 (1)

CHEBI ID

CHEBI:140929 (1)
CHEBI:140927 (1)
CHEBI:63990 (1)
CHEBI:53026 (1)
CHEBI:131992 (1)
CHEBI:140975 (1)
CHEBI:140978 (1)
CHEBI:140977 (1)
CHEBI:140976 (1)
CHEBI:140974 (1)
CHEBI:140973 (1)
CHEBI:140967 (1)
CHEBI:140966 (1)
CHEBI:140965 (1)
CHEBI:140964 (1)
CHEBI:140962 (1)
CHEBI:140961 (1)
CHEBI:140957 (1)
CHEBI:140956 (1)
CHEBI:140955 (1)
CHEBI:140954 (1)
CHEBI:140950 (1)
CHEBI:140960 (1)
CHEBI:89570 (1)
CHEBI:63999 (1)
CHEBI:91286 (1)
CHEBI:38265 (1)
CHEBI:71494 (1)
CHEBI:64235 (1)
CHEBI:64238 (1)

Metabolite Name

L-Histidine (3)
L-Glutamic acid (3)
Ascorbic acid (3)
Adenine (3)
Achyranthoside C (2)
1beta,2alpha,3beta,19alpha-Tetrahydroxy-12-ursen-28-oic acid 28-O-[b-D-Glucopyranosyl-(1->2)-b-D-glucopyranosyl] ester (2)
(7E,7'R,8'R)-e-Viniferin 3',5'-diglucoside (2)
PA(22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z)) (2)
TG(15:0/15:0/15:0) (2)
Desglucodesrhamnoparillin (2)
PA(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (2)
1-Acetyl-3,14,20-trihydroxywitha-5,24-dienolide 3-glucoside (2)
(S)-Nerolidol 3-O-[a-L-Rhamnopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->2)-b-D-glucopyranoside] (2)
Dephospho-CoA (2)
PA(15:0/20:3(8Z,11Z,14Z)) (2)
Quercilicoside A (2)
Cyclopassifloside VI (2)
Sericoside (2)
3-trans-p-Coumaroylrotundic acid (2)
(-)-Guttiferone E (2)
DG(20:1(11Z)/16:1(9Z)/0:0) (2)
Multinoside A (2)
DG(18:0/16:0/0:0) (2)
DG(20:1(11Z)/14:0/0:0) (2)
Hyacinthin (2)
(+)-7-epi-Syringaresinol 4'-glucoside (2)
Proanthocyanidin A2 (2)
Withaperuvin H (2)
FAHFA(16:0/12-O-18:0) (2)
Ganolucidic acid C (2)

First Public Date

2026 (3)
2023 (2)
2025 (1)
2014 (1)

Study status

Recruiting (2)
Active, not recruiting (1)
Not yet recruiting (1)

Study type

Transcription profiling by array (28)
RNA-seq of coding RNA (7)
Interventional (3)
RNA-seq of coding RNA from single cells (2)
Transcription profiling by SAGE (1)
RNA-seq of non coding RNA (1)
Observational (1)

Release Date

2025 (635)
2022 (593)
2023 (516)
2021 (471)
2024 (447)
2020 (361)
2019 (288)
2018 (230)
2017 (139)
2016 (92)
2015 (84)
2026 (83)
2014 (75)
2013 (37)
2012 (35)
2011 (24)
2010 (22)
2009 (21)
2008 (15)
2007 (10)
2005 (7)
2006 (3)
2004 (2)
2002 (1)

Lab affiliation

Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland (part of Philip Morris International group of companies) (2)
Proteome Center Rostock Department for Proteome Research Institute of Immunology Medical Faculty and Natural Science Faculty University of Rostock Schillingallee 69 18057 Rostock Germany (2)
Clinical Proteomics Laboratory, Institute of Chemistry, UPD (1)
Guangdong Medical University (1)
School of Life Sience, Sun Yat-sen University (1)
Henan University (1)
Clinical Medical Research Center, The Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital), Shenzhen, Guangdong;Department of Nephrology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong (1)
Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA (1)
Key Laboratory of Horticultural Plant Biology, MOE (1)
Department of Biochemistry, The University of Western Ontario, London, Ontario, Canada. (1)
National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen (1)
The University of Texas at El Paso (1)
Department of Radiation Biology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, China (1)
Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland (part of Philip Morris International group of companies) (1)

Location

Australia (2)
Germany (1)
United States (1)

Tags

xref:PubMed:40564983 (1)
xref:PubMed:41797911 (1)

Previous page
1 / 423
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 423
Next page

Sort by:

Relevance

Page size

Intact Transition Epitope Mapping-Targeted High-Energy Rupture of Extracted Epitopes (ITEM-THREE)

ITEM-THREE is a novel mass spectrometry-based epitope mapping method. To perform ITEM-THREE, antibody-epitope peptide immune-complexes are first generated in electrospray-compatible solutions in which the antibodies maintain their in-solution functionality, by adding an antibody of interest to a mi...

ORGANISM(S): Homo sapiens (Human)

2019-06-03 | PXD013823 | Pride